Home Page News Statistics API Review Formulation Monthly Im&Ex report All Information
     
Keyword:
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
　　Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Conference on ...
Information Release...
Internationalization&nbs...
Welcome to Pro...
Healthoo.com Carbap...
APIs Innovation&nbs...
China Import Export Statistics Report In...
API Export Price by ...
Tylosin Bulk Drug Export&...
China Monthly Export Stat...
China Monthly Export Stat...
China Monthly Export Stat...
Your position:www.healthoo.com >> EN >> Industry
SFDA issues risk warning for diet pill Orlistat2011-03-09
China announces 21% price cut on 162 medicines2011-03-07
Wuzhong Pharma to begin phase Ⅲ trial of rhEn for lung cancer2011-03-04
Health minister declare free care for more leukemia children2011-03-04
SFDA gets WHO approval for vaccine regulation2011-03-03
Sichuan builds EU compliance anticancer industrial park2011-03-02
Sanofi-aventis completes acquisition for BMP Sunstone in China2011-02-28
Kexing Biochem emerging as Biotin giant2011-02-25
DSM eyes expansion in China2011-02-25
Project of Glutathione into production in Gansu2011-02-24
Shanghai to add more HIV drugs into medical insurance catalogue2011-02-23
Tyroserleutide into III clinical trial for hepatoma in China2011-02-22
Access Standards of Vitamin C will be issued near future2011-02-21
7,743 die of AIDS on mainland China in 20102011-02-21
China to suppress antibiotics abuse2011-02-18
Export value of China's APIs increases by 26% in 20102011-02-16
New edition GMP put into practice from March 1st2011-02-15
Export value of Traditional Chinese Medicine reaches  times="32".9 bn in 20102011-02-11
SFDA ordered to withdrawn dextropropoxyphene from the market2011-02-10
Eli Lilly files 337 complaint for China's Gemcitabine2011-01-28
Effect analysis on India's antidumpling policy2011-01-27
Foreign firms tend to quit from the bidding of essential drugs2011-01-27
India made antidumping duty for China's 6-APA and Penicillin G Potassium2011-01-26
New GMP will be issued soon2011-01-24
Baiyunshan begins to produce Prulifloxacin tablets2011-01-21
Healthcare expanditure approaches 2000 billion yuan in 20102011-01-20
Market size of antibiotics in China2011-01-19
China to strengthen TCM research and development2011-01-18
New Insulin project is built in Jiangsu2011-01-17
Shanghai Pharma acquires most stake of CHS2011-01-17
Xuezhikang starts Phase Ⅱ clinical trials in USA2011-01-17
SFDA vows to insure quality of essential medicine2011-01-14
共1471个 页次:24/46页 32个/页 首页 上一页 下一页 尾页 转到：
Our Advantages of Reports
①All reports written by ourselves
②All data having original sources
③Information is the latest
④Continuous historical data
⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract)
②Transfer payment to company's bank account
③After accepting payment we email the report to clients (PDF format)
④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd
②Beneficiary's Account No.:110060239018002127366
③Name of bank:Bank of Communications Beijing Branch，Fuwai Sub-Branch
④Address of bank:NO7，FUWAISTREET，XICHENG DISTRICT，BEIJING，CHINA SWIFT CODE：COMMCNSHBJG
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463